SCHEMBL24915560

SCHEMBL24915560

COc1cc(C(=O)Nc2cn[nH]c2)c2nc(C)cc(C(C)C)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.50
MTOR P42345 3/20 0.50
HPGDS O60760 1/20 0.44
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KCNK3 O14649 1/20 0.35
KCNK9 Q9NPC2 1/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
JAK3 P52333 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ATF1 P18846 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915921 0.81 MTNR1A (0.43) KDM4EALDH1A1MAPTHPGDJAK2
SCHEMBL29923902 0.80 HPGDS (0.53) PIK3CAMTORHPGDSKDM4EALDH1A1
SCHEMBL24915568 0.78 KDM4E (0.36) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL24916230 0.78 SCN9A (0.36) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL24916058 0.78 KDM4E (0.50) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL24915570 0.77 CSNK2A2 (0.39) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL24915923 0.77 CD38 (0.45) KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL24915919 0.74 HPGD (0.43) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL24915573 0.72 KMT2A (0.43) KDM4EALDH1A1HPGDKMT2A
SCHEMBL24915974 0.68 KMT2A (0.40) MAPTJAK2LMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 PIK3CA 1862/4885MTOR 550/4885HPGDS 2697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.